RBO-0618

N/A

Report date: 2023/07/28 15:56:42
NMEFirst In Class

Base Information

Drug NameRBO-0618
Drug Alias NameRBO-0618
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell death stimulants
TargetsUpdating
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRubedo Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesRubedo Life Sciences Inc
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A